Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by TriumphSpitSixon Feb 08, 2021 9:52pm
152 Views
Post# 32508902

RE:Share activity

RE:Share activityI don't know if the "opening bell effect" would be the sole reason for today's jump but it does significantly increase the company's exposure to a wider audience, even if the event itself was virtual.

From TSX/TMX website:

"Market Open Ceremonies at Toronto Stock Exchange (TSX) provide an opportunity to generate exposure for listed companies and select organizations. The market opens are broadcast live on the Business News Network morning show and live streamed on YouTube. The event is also featured on TSX.com and TMX.com, and shared through Twitter and Facebook."

I have no idea how many people who didn't already know it might have been exposed to the name Antibe Therapeutics today, but I'd wager it's a lot!


 
Jefnan1 wrote: There is no way today's activity has anything to do with the opening bell. I read the daily comments on here and can't believe the people who think the share movements either up or down have anything to do with the factors that  effect a mature company on a daily basis. This is a speculative drug development company so if you believe the proof of concept than you shouldn't care what happens on a daily basis. 


<< Previous
Bullboard Posts
Next >>